MedTrace Logo

Complex Exploratory Study of Alcohol-Associated Hepatitis

NCT06358196 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-04-10

No results posted yet for this study

Summary

Alcohol-associated hepatitis is a clinical syndrome distinct from steatohepatitis or liver cirrhosis. It is associated with high mortality and characterized by an absence of effective treatment, while corticosteroids, which are currently used as the first-line treatment are effective only in a subpopulation of patients and only on 28-days survival - their effect on survival does not last beyond this interval. The proposed study is a complex exploratory study of alcohol-associated hepatitis with several epidemiology- and prognosis-related aims.

Conditions

  • Alcoholic Hepatitis

Sponsors & Collaborators

  • L Pasteur University Hospital

    collaborator UNKNOWN

  • Hospital Agel Kosice-Saca

    collaborator UNKNOWN

  • Technical University in Kosice

    collaborator UNKNOWN

  • Western University

    collaborator OTHER

  • University of Roma La Sapienza

    collaborator OTHER

  • Pavol Jozef Safarik University

    lead OTHER

Principal Investigators

  • Jakub Gazda, MD, PhD · Pavol Jozef Safarik University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-04-30
Completion
2026-04-30

Countries

  • Slovakia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06358196 on ClinicalTrials.gov